Joint Formulary & PAD

Dorzolamide - Glaucoma / ocular hypertension

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Eye drops
Associated Icons :
Restrictions / Comments :
 

Status 2

Blue
Formulations :
  • Eye drops (preservative free)
Associated Icons :
Restrictions / Comments :
Important

Preservative free dorzolamide 20mg/ml - more cost effective if prescribed as a 10ml bottle.
Reserve the use of unit dose formulations for patients for whom a bottle is not suitable.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Dorzolamide
Indication :
Glaucoma / ocular hypertension
Group Name :
Keywords :
Intra-ocular pressure
Brand Names Include :
Trusopt, Vizidor, Eydelto
Important Information :

Prescribe generically. Initiation by specialist team before any request is made to transfer prescribing to primary care

Latest Additions Date From :
Latest Additions Date To :
Supporting Documents :
0
Traffic Light Entries :
2

Committee Recommendations (2)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

Primary care prescribers do not have the necessary equipment or skills to perform ocular pressure readings to make a diagnosis. The APC recomments that this product, when used for treatment of glaucoma, should be considered as BLUE.

Note; the branded product (Trusopt) was considered BLACK at the PCN in May 2017.